Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Colorcon
Mallinckrodt
Medtronic
McKinsey

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for BRL-15,572

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug BRL-15,572?

BRL-15,572 is an investigational drug.

There have been 5 clinical trials for BRL-15,572. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2000.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Leishmaniasis. The leading clinical trial sponsors are GlaxoSmithKline, Directorate General of Health Services of Bangladesh, and National Taiwan University Hospital.

Recent Clinical Trials for BRL-15,572
TitleSponsorPhase
A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic LeukemiaCelgenePhase 1/Phase 2
A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic LeukemiaMundipharma Research GmbH & Co KGPhase 1/Phase 2
A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic LeukemiaRoche Pharma AGPhase 1/Phase 2

See all BRL-15,572 clinical trials

Clinical Trial Summary for BRL-15,572

Top disease conditions for BRL-15,572
Top clinical trial sponsors for BRL-15,572

See all BRL-15,572 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Baxter
Merck
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.